PMID

Data

Article Title

Organization

Exploring Fatty Acid Mimetics as NR4A Ligands.

Ludwig Maximilian University of Munich

Development of a Potent Nurr1 Agonist Tool for In Vivo Applications.

Ludwig Maximilian University of Munich

Discovery of orally active 1,4,5,6,8-pentaazaacenaphthylens as novel, selective, and potent covalent BTK inhibitors for the treatment of rheumatoid arthritis.

China Pharmaceutical University

Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-

Biocon-Bristol Myers Squibb Research and Development Center

4-Aminopyrazolopyrimidine scaffold and its deformation in the design of tyrosine and serine/threonine kinase inhibitors in medicinal chemistry.

Yangtze University

Design, synthesis and biological evaluation of 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as selective Btk inhibitors with improved pharmacokinetic properties for the treatment of rheumatoid arthritis.

Sichuan University and Collaborative Innovation Center